Trial intelligence / Profile preview

Amitriptyline Effects on Driving Performance in Chronic Neuropathic Pain Patients

NCT00189059Phase 4Terminated

Start
Oct 2002
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of amitriptyline in chronic neuropathic pain (2 arms). Primary endpoint: Driving parameters at Day 15. Started Oct 2002; status: terminated.

02

Drugs

amitriptyline
03

Conditions

chronic neuropathic pain

Beyond the preview

Go deeper on NCT00189059.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00189059.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call